Navigation Links
Cellegy Pharmaceuticals Announces Signing of Definitive Merger Agreement
Date:2/12/2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2008)... Histogen, Inc., a regenerative medicine compa...ewborn fibroblasts, will be featured in an upcomin...st Century Breakthroughs for Biomedical Research s...EB) December 5, 2008 -- Histogen, Inc., a regenera...n the products of newborn fibroblasts, will be fea...
(Date:12/5/2008)... Dec. 5 Genomic Health,...ompany will present results from,four studies at ...m, taking,place December 10-14, 2008, at the Henr...ies analyze Oncotype DX(R), the company,s multi-ge...to predict the likelihood of chemotherapy,benefit...
(Date:12/5/2008)...Dec. 5 Senesco Technolog...next US: SNT) announced today that its Development...o.com ("Harris Moran") has been terminated by mut...nnounced corporate restructuring. , , Harr...agrain, restructured its vegetable seed operations...
(Date:12/5/2008)... fistula closures observed in PRECiSE 2 trial unde...(R) every four weeks , , HOLLYWOOD, Fla., D...s week by UCB at Advances in Inflammatory Bowel Di...s Clinical & Research Conference, demonstrated...e Crohn,s disease patients who had open fistulas a...
Breaking Biology Technology:Histogen Featured on Economic Report Television Series 2Genomic Health to Present Multiple New Studies at 31st Annual San Antonio Breast Cancer Symposium 2Genomic Health to Present Multiple New Studies at 31st Annual San Antonio Breast Cancer Symposium 3Senesco and Harris Moran Mutually Agree to Terminate Development and License Agreement Due to Restructuring 2Senesco and Harris Moran Mutually Agree to Terminate Development and License Agreement Due to Restructuring 3New Data Suggest CIMZIA(R) (Certolizumab Pegol) Active in Treating Moderate to Severe Crohn's Patients With Fistulizing Disease 2New Data Suggest CIMZIA(R) (Certolizumab Pegol) Active in Treating Moderate to Severe Crohn's Patients With Fistulizing Disease 3New Data Suggest CIMZIA(R) (Certolizumab Pegol) Active in Treating Moderate to Severe Crohn's Patients With Fistulizing Disease 4New Data Suggest CIMZIA(R) (Certolizumab Pegol) Active in Treating Moderate to Severe Crohn's Patients With Fistulizing Disease 5New Data Suggest CIMZIA(R) (Certolizumab Pegol) Active in Treating Moderate to Severe Crohn's Patients With Fistulizing Disease 6New Data Suggest CIMZIA(R) (Certolizumab Pegol) Active in Treating Moderate to Severe Crohn's Patients With Fistulizing Disease 7New Data Suggest CIMZIA(R) (Certolizumab Pegol) Active in Treating Moderate to Severe Crohn's Patients With Fistulizing Disease 8New Data Suggest CIMZIA(R) (Certolizumab Pegol) Active in Treating Moderate to Severe Crohn's Patients With Fistulizing Disease 9
...pose , Normal phase chromatography can b...the API 3000 LC/MS/MS System. , Overview ...ies have placed greater importance on examining th...ral center. Isomerspecific pharmaceuticals often e...nd reduced side effects when compared to racemic p...
...pose , Increased throughput in drug deve... 3000 LC/MS/MS System for N-in-1 experiments. Pate...ole in maximizing throughput by enabling faster sc... Overview , A significant area in whic...-1 studies (also referred to as cassette dosing or...
...al Analysis of Gene Expression (SAGE) is a sequenc...tially expressed genes by comparative analyses. SA...ve methods available for detailed analysis of larg...ofile of the expressed genes. 1 SAGE provides an ...els of genes expressed in a specimen. The ability ...
...pose , A previously published applicatio... for the simultaneous determination of four immuno... (TAC, aka FK-506), Sirolimus (SIR, aka Rapamycin)...hod is based on a simple and robust hardware confi...compromising precision and accuracy. Since this me...
Other Biology Technology:Separation and Quantitation of R and S Enantiomers using Normal Phase Chromatography on an API 3000 LC/MS/MS System 2Separation and Quantitation of R and S Enantiomers using Normal Phase Chromatography on an API 3000 LC/MS/MS System 3Detection of N-in-1 Experiments: Extending the Range of N Using the API 3000 LC/MS/MS System 2Detection of N-in-1 Experiments: Extending the Range of N Using the API 3000 LC/MS/MS System 3Serial Analysis of Gene Expression Using ABI PRISM DNA Sequencers and BigDye Terminators 2Serial Analysis of Gene Expression Using ABI PRISM DNA Sequencers and BigDye Terminators 3Serial Analysis of Gene Expression Using ABI PRISM DNA Sequencers and BigDye Terminators 4Serial Analysis of Gene Expression Using ABI PRISM DNA Sequencers and BigDye Terminators 5A new LC/MS/MS Research Method for Rapid Quantitation of Five Immunosuppressant Drugs, including Mycophenolic Acid (MPA) 2A new LC/MS/MS Research Method for Rapid Quantitation of Five Immunosuppressant Drugs, including Mycophenolic Acid (MPA) 3A new LC/MS/MS Research Method for Rapid Quantitation of Five Immunosuppressant Drugs, including Mycophenolic Acid (MPA) 4A new LC/MS/MS Research Method for Rapid Quantitation of Five Immunosuppressant Drugs, including Mycophenolic Acid (MPA) 5
(Date:12/3/2008)...the box office this week. The most exciting new fi...lmed by scientists using ground-breaking technolog...s at Sydney,s Centenary Institute have filmed an i...lowed the infection as it begins to spread through...ad of the Immune Imaging program at the Centenary ...
(Date:12/3/2008)... 2008. The first 5-year forest inventory report fo...le to the public: Oregon,s Forest Resources, 2001-...rt. , Here are some key findings from the report...es; about half of Oregon,s total land area of 61 m... other uses particularly near urban areas. The rat...
(Date:12/3/2008)...gh they may not help improve a person,s golf game,...hink about the local country club in the near futu..., "There are more than 17,000 golf courses in th...hat land is not used for playing," said Ray Semlit...ege of Arts and Science. "These managed green spac...
(Date:12/3/2008)...rsity study suggests that evolution can behave as ...d on an energy-efficient style of four-footed runn...seem to have evolved a profoundly inefficient gait...ow motion. , "It is usually assumed that efficie...mitt, a Duke associate professor of evolutionary a...
Breaking Biology News(10 mins):Scientists film inner workings of the immune system 2Forest inventories in Oregon include more than trees 2Forest inventories in Oregon include more than trees 3Golf course: Playing fields, wildlife sanctuaries or both 2Dogs chase efficiently, but cats skulk counterintuitively 2Leventhal Weight Loss Incorporated President Mark Leventhal to Address Frederick County Bar 12387 1Leventhal Weight Loss Incorporated President Mark Leventhal to Address Frederick County Bar 12387 2Novocell Reports Successful Use of Stem Cells to Generate Insulin in Mice 3438 1Novocell Reports Successful Use of Stem Cells to Generate Insulin in Mice 3438 2Novocell Reports Successful Use of Stem Cells to Generate Insulin in Mice 3438 33SBio Inc Announces Unaudited Fourth Quarter and Fiscal Year 2007 Results 3433 13SBio Inc Announces Unaudited Fourth Quarter and Fiscal Year 2007 Results 3433 23SBio Inc Announces Unaudited Fourth Quarter and Fiscal Year 2007 Results 3433 33SBio Inc Announces Unaudited Fourth Quarter and Fiscal Year 2007 Results 3433 43SBio Inc Announces Unaudited Fourth Quarter and Fiscal Year 2007 Results 3433 53SBio Inc Announces Unaudited Fourth Quarter and Fiscal Year 2007 Results 3433 63SBio Inc Announces Unaudited Fourth Quarter and Fiscal Year 2007 Results 3433 73SBio Inc Announces Unaudited Fourth Quarter and Fiscal Year 2007 Results 3433 83SBio Inc Announces Unaudited Fourth Quarter and Fiscal Year 2007 Results 3433 93SBio Inc Announces Unaudited Fourth Quarter and Fiscal Year 2007 Results 3433 103SBio Inc Announces Unaudited Fourth Quarter and Fiscal Year 2007 Results 3433 113SBio Inc Announces Unaudited Fourth Quarter and Fiscal Year 2007 Results 3433 123SBio Inc Announces Unaudited Fourth Quarter and Fiscal Year 2007 Results 3433 133SBio Inc Announces Unaudited Fourth Quarter and Fiscal Year 2007 Results 3433 143SBio Inc Announces Unaudited Fourth Quarter and Fiscal Year 2007 Results 3433 153SBio Inc Announces Unaudited Fourth Quarter and Fiscal Year 2007 Results 3433 16NYC Department of Healths Get Some NYC Condoms Sends Wrong Message and Misuses Tax Dollars says MIM President Bob Peters 1398 1NYC Department of Healths Get Some NYC Condoms Sends Wrong Message and Misuses Tax Dollars says MIM President Bob Peters 1398 2
...esearchers at the University at Buffalo has been s...with human breast-cancer tumors and to inhibit the...re than 50 percent. , The antibody, named JAA-F11,...wn as TF-Ag, which aids the adhesion and spread of... kill the cancer cells, it blocked stages of cance...
...versity of Minnesota, Extension food scientist Joe...th a water-based electrochemical activation system...i. , While electrolyzed water systems are not new...ntists, is unique because it produces a pH-neutral...avors when sprayed on food. The system is environm...
... biochemical marker linked to sleep loss, an enzym...ctivity when sleep deprivation is prolonged. , Res... of biomarkers that will aid diagnosis and treatme...the risk of falling asleep at the wheel of a car o... for the holiday season and long drives to distant...
...an be accelerated with the assistance of the molec... a team of researchers at the U.S. Department of E...und. Nanoparticles, particles with dimensions on t...ly be used for more efficient energy generation an...agnosing and treating disease. Learning how to con...
Other Biology News:Antibody extends life of mice with breast cancer 2First biomarker for human sleepiness identified in fruit flies 2First biomarker for human sleepiness identified in fruit flies 3Nanoparticle assembly enters the fast lane 2
RABBIT ANTI PORCINE CARBOXYPEPTIDASE B
LabFax: Immunochemistry
...ular system for large format and medium throughput...cast gels (26 x 20 cm) simultaneously.Use with 18-....0-mm or 1.5-mm pre-assembled hinged gel cassettes...g.Built-in ceramic heat exchanger and buffer circu...
Mycoplasma Removal Agent (MRA) has been developed for cell culture, to combat the widespread problems caused by contamination of cell cultures with mycoplasma.
Biology Products: